Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPT-DP vs IPT-SPCQ in Schoolchildren
NCT05980156Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2023
- Primary completion
- Jul 2023
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine, sulfadoxine + pyrimethamine, chloroquine in Malaria, sponsored by University of Maryland, Baltimore. Started Feb 2023; status: completed.
02
Drugs
dihydroartemisinin + piperaquinesulfadoxine + pyrimethaminechloroquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT05980156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05980156.